glp-1 and colonoscopy This randomized clinical trial evaluated the risk of clinically significant residual gastric volume in adults undergoing elective upper endoscopy while receiving glucagon-like peptide-1 (#GLP1) or glucose-dependent insulinotropic polypeptide (GIP Unmasking Aspiration Risks: A Propensity‐Matched
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16







01375-3/asset/bffa03de-3da9-472a-a80e-74f8a67c6fdd/main.assets/gr2.jpg)




















